https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-02-05 / Cancer Immunol Res 2014 May;2(5):404-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-02-05 / Cancer Immunol Res 2014 May;2(5):404-92014-02-05 00:00:002019-02-15 08:48:45Long-term complete remission following radiosurgery and immunotherapy in a melanoma patient with brain metastasis: immunologic correlates
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-02-01 / Transl Lung Cancer Res 2014 Feb;3(1):53-63
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-02-01 / Transl Lung Cancer Res 2014 Feb;3(1):53-632014-02-01 00:00:002019-02-15 08:35:18Immunotherapy in lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-02-01 / Anticancer Res. 2014 Feb;34(2):565-74
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-02-01 / Anticancer Res. 2014 Feb;34(2):565-742014-02-01 00:00:002014-02-01 00:00:00Fighting fire with fire: the revival of thermotherapy for gliomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-02-01 / Transl Lung Cancer Res 2014 Feb;3(1):34-45
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-02-01 / Transl Lung Cancer Res 2014 Feb;3(1):34-452014-02-01 00:00:002014-02-01 00:00:00Immunotherapy prospects in the treatment of lung cancer and mesothelioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-01-13 / Hum Vaccin Immunother 2014;10(4):970-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-01-13 / Hum Vaccin Immunother 2014;10(4):970-62014-01-13 00:00:002014-01-13 00:00:00Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-01-06 / Oncoimmunology 2014 Jan;3(1):e27622
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-01-06 / Oncoimmunology 2014 Jan;3(1):e276222014-01-06 00:00:002019-02-15 09:21:25Two is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-01-03 / Cancer Gene Ther. 2014 Jan;21(1):24-30
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-01-03 / Cancer Gene Ther. 2014 Jan;21(1):24-302014-01-03 00:00:002014-01-03 00:00:00Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-01-03 / Cancer Immunol. Immunother. 2014 Apr;63(4):321-33
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-01-03 / Cancer Immunol. Immunother. 2014 Apr;63(4):321-332014-01-03 00:00:002019-02-15 08:39:42Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8(+) T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-01-01 / Hum Vaccin Immunother 2014;10(11):3125-31
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-01-01 / Hum Vaccin Immunother 2014;10(11):3125-312014-01-01 00:00:002019-02-15 08:32:45Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-01-01 / CNS Oncol 2014;3(5):337-48
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-01-01 / CNS Oncol 2014;3(5):337-482014-01-01 00:00:002019-02-15 08:32:55Diffuse intrinsic pontine glioma: time for therapeutic optimism
